BioNote, Inc. (KRX:377740)
South Korea · Delayed Price · Currency is KRW 5,290.00
+20.00 (0.38%)
Last updated: Aug 14, 2025
BioNote Market Cap
BioNote has a market cap or net worth of 547.35 billion as of August 14, 2025. Its market cap has increased by 30.65% in one year.
Market Cap
547.35B
Enterprise Value
163.16B
Revenue
105.92B
Ranking
n/a
PE Ratio
12.97
Stock Price
5,290.00
Market Cap Chart
Since December 22, 2022, BioNote's market cap has decreased from 1.08T to 547.35B, a decrease of -49.55%. That is a compound annual growth rate of -22.78%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 14, 2025 | 547.35B | 13.87% |
| Dec 30, 2024 | 480.68B | 10.95% |
| Dec 28, 2023 | 433.23B | -50.44% |
| Dec 29, 2022 | 874.10B | -19.44% |
| Dec 22, 2022 | 1,084.98B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 73.45T |
| Celltrion | 38.14T |
| ALTEOGEN | 22.98T |
| Yuhan | 8,383.50B |
| SK Biopharmaceuticals | 7,737.35B |
| PharmaResearch | 7,064.96B |
| Peptron | 6,989.21B |
| LigaChem Biosciences | 5,419.69B |